BRIEF published on 01/27/2025 at 12:35, 1 year 6 months ago NanoViricides fait passer le NV-387 à l'essai clinique de phase II NanoViricides NV-387 Essai Clinique Médicament Antiviral Traitement MPox
PRESS RELEASE published on 01/27/2025 at 12:30, 1 year 6 months ago NanoViricides Engages CRO for Phase II Clinical Trial NanoViricides, Inc. engages a Clinical Research Organization for Phase II trial of broad-spectrum antiviral drug NV-387 targeting MPox virus infection. Drug aims to combat viral diseases effectively NanoViricides NV-387 Clinical Trial Antiviral Drug Mpox Virus
BRIEF published on 01/13/2025 at 12:35, 1 year 7 months ago NanoViricides to Present Breakthrough Antiviral Developments at Biotech Showcase NanoViricides NV-387 Biotech Showcase Clinical Trials Antiviral Drugs
BRIEF published on 01/13/2025 at 12:35, 1 year 7 months ago NanoViricides présentera ses avancées antivirales révolutionnaires au Biotech Showcase NanoViricides NV-387 Essais Cliniques Médicaments Antiviraux Vitrine Biotechnologique
PRESS RELEASE published on 01/13/2025 at 12:30, 1 year 7 months ago NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 NanoViricides, Inc. to present Phase II-ready drug NV-387 at Biotech Showcase 2025 in San Francisco, demonstrating broad-spectrum antiviral activity against various infections NV-387 NanoViricides Inc. Antiviral Drug San Francisco Biotech Showcase 2025
BRIEF published on 01/08/2025 at 12:35, 1 year 7 months ago Broad-Spectrum Antivirals: A Necessity Amid Multiple Viral Threats NanoViricides NV-387 Broad-spectrum Antivirals RNA Viruses Viral Resistance
BRIEF published on 01/08/2025 at 12:35, 1 year 7 months ago Antiviraux à large spectre : une nécessité face aux multiples menaces virales NanoViricides NV-387 Antiviraux À Large Spectre Virus À ARN Résistance Virale
PRESS RELEASE published on 01/08/2025 at 12:30, 1 year 7 months ago Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals NanoViricides, Inc. President Dr. Anil Diwan comments on multiple pandemic-causing viruses worldwide, highlighting NV-387's broad-spectrum antiviral capabilities NanoViricides NV-387 Antiviral Broad-spectrum Pandemic
BRIEF published on 12/23/2024 at 12:35, 1 year 7 months ago NanoViricides Positions NV-387 as Key Player Against Bird Flu NanoViricides NV-387 Antiviral Drug H5N1 Virus Bird Flu
BRIEF published on 12/23/2024 at 12:35, 1 year 7 months ago NanoViricides positionne le NV-387 comme un acteur clé dans la lutte contre la grippe aviaire NanoViricides NV-387 Virus H5N1 Médicament Antiviral Grippe Aviaire
Published on 08/15/2026 at 00:50, 9 hours 27 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 10 hours 2 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 10 hours 32 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 10 hours 52 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 11 hours 17 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 2 hours 12 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 16 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 18 hours 12 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 16 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 16 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 16 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 16 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 16 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
